A New Synthetic Mutant of Endotoxin Binding Peptide Attenuates Endotoxininduced Inflammatory Responses in Vitro and in Vivo

XU Xiaoming,DUAN Guangjie,ZHU Jiang,XU Jianhua,LIU Yousheng
DOI: https://doi.org/10.13431/j.cnki.immunol.j.20120054
2012-01-01
Abstract:Residues 91-108 of human lipopolysaccharide binding protein(Endotoxin binding peptide,EBP) have been proved with obvious anti-LPS effects.This study is designed to identify whether mutant of Endotoxin binding peptide(mEBP) possess stronger anti-LPS effects than EBP in vitro and in vivo.EBP and mEBP were synthesized by the solid phase peptide synthesis method on a peptide synthesizer by F-moc chemistry.The impact of mEBP on RAW264.7 cells proliferation was detected by cell counting Kit-8 assay,the effect of mEBP on the secretion of cytokines of LPS-induced RAW264.7 cells was detected by ELISA,the influence of mEBP on p-p38 MAPK expression of LPS-induced RAW264.7 cells was detected by Western blot analysis,and the influence of mEBP on pinocytosis of LPS-induced RAW264.7 cells was detected by neutral red pinocytosis test.Mouse model of burn combined with endotoxemia was established,and the plasma levels of ALT,AST,and TNF-α were determined 6 h after modeling,while survival rate was monitored within 48 h.Results showed that mEBP had no cytotoxicity;mEBP could inhibited significantly the secretion of cytokines by RAW264.7 cells,the activation of p-p38 MAPK signaling pathway,and the pinocytosis ability of RAW264.7 cells.Compared with the model group,the plasma concentrations of ALT and AST,and TNF-α were significantly reduced by mEBP,the survival rate of mouse model of burn combined with endotoxemia was improved by mEBP.These results provide evidence that mEBP possesses stronger anti-endotoxin bioactivity than EBP,suggested that mEBP may be useful in the treatment of LPS-associated inflammation.
What problem does this paper attempt to address?